Eleuthero (Siberian Ginseng)
Adaptogen from Northern Asia / Russian Far East — the original "Russian adaptogen" studied extensively in Soviet-era sport-medicine and military performance literature. | Compound
Aliases (5)
▸ Overview TL;DR
Adaptogen from Northern Asia / Russian Far East — the original "Russian adaptogen" studied extensively in Soviet-era sport-medicine and military performance literature. Not a true ginseng (different genus from Panax) — the "Siberian ginseng" name is a marketing artifact, not a botanical or pharmacological accuracy. Active constituents are eleutherosides B and E (lignan-related glycosides). Best-evidenced uses: stress resilience, mild immune support, fatigue resistance under physical load. For Dylan: OPTIONAL-ADD low priority; V4 rhodiola is the better-evidenced adaptogen for the same goals. Useful in immune-frequency-illness archetypes.
▸ Mechanism of action
Eleutherococcus senticosus is a thorny shrub native to Northeast Asia. The roots and rhizomes contain eleutherosides A through M plus polysaccharides, lignans, and triterpenoid saponins. Standardized extracts target eleutheroside B + E content (typically ≥0.8%).
Mechanism dimensions:
1. HPA-axis modulation:
- Eleutherosides modulate cortisol response to acute stress in animal models
- Reduces ACTH and cortisol elevation in stress paradigms
- Mechanism less crisply defined than rhodiola's monoamine angle — likely indirect via hippocampal glucocorticoid receptor sensitivity
2. Immune modulation:
- Polysaccharides activate macrophages, NK cells, and T-cell populations in vitro and in vivo
- Bohn 1987 (German trial) — eleuthero extract increased CD3+ and CD4+ lymphocytes in healthy volunteers
- Mild signal for reducing common cold severity/duration in Russian/German trials
3. Cognitive endurance / fatigue:
- Soviet sports-medicine literature (1960s-70s): improved physical work capacity, reduced perceived exertion
- Not a stimulant — described as "fatigue ceiling raise" rather than "energy boost"
- Mechanism likely indirect via stress smoothing rather than direct CNS effect
4. Mild anti-inflammatory + antioxidant:
- Eleutherosides have modest free-radical scavenging activity
- Reduces inflammatory marker elevations in animal stress models
5. Cardiovascular:
- Mild vasodilation reported
- Some Russian data on improved cardiovascular endurance in athletes
Pharmacokinetics: Eleutherosides have moderate oral bioavailability; effects typically build over 2-6 weeks of consistent dosing.
▸ Pharmacokinetics No data
▸ What to expect Generic
- 1Week 1Tolerability and dose-response.
- 2Week 2-4Early effect window.
- 3Week 4-8Peak benefit assessment.
- 4Week 8+Cycle decision point.
▸ Side effects + safety
- Common (>10%): Mild GI upset, drowsiness in some users
- Less common (1-10%): Mild headache, hypertension at high doses (sympathomimetic-like signal, less than Panax ginseng)
- Rare-serious (<1%): Allergic reactions; theoretical hypoglycemia
- Specific watch periods: Blood pressure if hypertension-prone
▸Interactions6 compounds
- rhodiolaSynergistic(Dylan's V4): Both are classical Russian adaptogens; rhodiola is more stimulating, eleuthero more immune-skewed
- schisandraSynergisticRussian "ADAPT-232" three-adaptogen combo
- panax-ginsengSynergisticCompound adaptogen approach but increases stim-like signal
- vitamin CSynergistic(Dylan's V4): Immune support compound stack
- Other CNS stimulants at high dosesAvoidMild additive sympathomimetic
- Anticoagulants (warfarin)AvoidTheoretical interaction; case reports